CJC-1295 & GHRP-2 Blend (10mg)

At Core Peptide, we provide research-grade peptides in the United States for laboratories, universities, and independent research facilities. The CJC-1295 & GHRP-2 Blend (10mg) is a carefully prepared peptide formulation intended strictly for scientific and laboratory research purposes.

This peptide blend is frequently examined by research teams investigating growth hormone (GH) signaling, receptor-specific activity, and endocrine system pathways. By combining two peptides that appear to act on distinct receptors, researchers have hypothesized that this blend may demonstrate synergistic activity in controlled experimental models.

Research Use Only Disclaimer:
The CJC-1295 & GHRP-2 Blend (10mg) is not intended for human or veterinary use. It is not a drug, supplement, or medical treatment and has not been approved by the FDA. Please review our Terms and Conditions before ordering.

Understanding the CJC-1295 & GHRP-2 Peptide Blend

The CJC-1295 & GHRP-2 Blend (10mg) combines two synthetic peptides commonly studied in growth hormone research due to their complementary mechanisms of action.

CJC-1295

CJC-1295 is a synthetic analog derived from Growth Hormone–Releasing Hormone (GHRH 1-29), which represents the shortest functional sequence of native GHRH capable of receptor activation. Research suggests that CJC-1295 exhibits affinity for GHRH receptors (GHRH-R) located in the anterior pituitary gland.

This peptide includes:

• Tetrasubstitution for increased molecular stability

• A Drug Affinity Complex (DAC) modification that may allow interaction with plasma proteins

These structural features are often explored for their potential effect on peptide half-life and sustained receptor engagement in laboratory settings.

GHRP-2 (Growth Hormone Releasing Peptide-2)

GHRP-2, also known as Pralmorelin, is a synthetic hexapeptide composed of six amino acids. Research indicates that GHRP-2 binds to growth hormone secretagogue receptors (GHS-R1a), which are expressed in both the hypothalamus and pituitary gland.

Due to this receptor specificity, GHRP-2 is commonly categorized as a growth hormone secretagogue (GHS) in scientific literature and is frequently studied alongside GHRH analogs such as CJC-1295.

Synergistic Research Interest

The primary research interest in the CJC-1295 & GHRP-2 Blend (10mg) lies in the hypothesis that these peptides may stimulate growth hormone release through separate biochemical pathways:

• CJC-1295 → GHRH receptor activation

• GHRP-2 → GHS-R1a receptor activation

Because these receptors operate independently, research suggests that their combined use may result in enhanced pulsatile GH secretion compared to individual peptide exposure. Several studies report that this dual-pathway stimulation may elevate both basal and pulsatile growth hormone levels in experimental models.

Research on Growth Hormone Secretion

Scientific investigations have explored how the CJC-1295 & GHRP-2 Blend may influence GH secretion dynamics. In controlled settings, researchers observed:

• Increased plasma GH concentrations

• Prolonged GH release compared to native GHRH

• Sustained activity potentially linked to the DAC component of CJC-1295

Some studies have reported significant fold-increases in pulsatile GH secretion when GHRH mimetics and GHRP compounds were combined, highlighting the importance of this blend in endocrine research.

Metabolic and Energy Balance Research

Growth hormone plays a central role in energy metabolism, lipid utilization, and nutrient partitioning. As a result, the CJC-1295 & GHRP-2 Blend (10mg) has been explored in research models focused on muscle and fat metabolism.

Research suggests that GH may:

• Promote lipolysis

• Increase fatty acid oxidation

• Influence glucose utilization

However, due to its ghrelin-like activity, GHRP-2 is also associated in studies with increased appetite signaling. This has led researchers to hypothesize that the blend may be more relevant for anabolic and lean mass research, rather than isolated fat-loss models.

Appetite and Ghrelin Signaling Studies

GHRP-2’s interaction with GHS-R1a receptors has been studied for its potential role in appetite regulation. Research models suggest this interaction may:

• Activate neuropeptides such as NPY and AgRP

• Influence hypothalamic hunger signaling

• Modulate overall energy intake

These findings emphasize the importance of evaluating systemic endocrine effects when studying the CJC-1295 & GHRP-2 Blend in laboratory environments.

IGF-1 and Anabolic Pathway Research

Another major area of scientific interest involves insulin-like growth factor-1 (IGF-1). Research suggests that elevated GH levels may stimulate IGF-1 synthesis in the liver via the JAK-STAT signaling pathway.

IGF-1 is widely studied for its role in:

• Cellular growth and proliferation

• Protein synthesis

• Tissue development

Experimental data indicates that CJC-1295 exposure may elevate IGF-1 concentrations for extended periods, making the CJC-1295 & GHRP-2 Blend (10mg) valuable for long-term endocrine signaling research.

Chemical Profile

Molecular Formula

• CJC-1295: C₁₅₂H₂₅₂N₄₄O₄₂

• GHRP-2: C₄₅H₅₅N₉O₆

Molecular Weight

• CJC-1295: 3367.9 g/mol

• GHRP-2: 817.9 g/mol

Other Known Names

• CJC-1295: GHRH derivative, GRF 1-29 albumin conjugate

• GHRP-2: Pralmorelin, GPA-748

Quality Commitment at Core Peptide

When ordering CJC-1295 & GHRP-2 Blend (10mg) from CorePeptide.us, U.S. researchers benefit from:

• Research-grade peptide handling

• Clear RUO labeling

• Secure packaging for laboratory storage

• Transparent sourcing and documentation

Explore our full Research Peptides Collection or learn more about our standards on the About Us page.

External Scientific References

Researchers may consult the following peer-reviewed sources for additional context:

• PubMed – Pulsatile GH Secretion and CJC-1295
  https://pubmed.ncbi.nlm.nih.gov/17018654/

• PubMed – GHRP-2 and Muscle Metabolism
  https://pubmed.ncbi.nlm.nih.gov/18191156/

• NCBI – CJC-1295 Compound Summary
  https://pubchem.ncbi.nlm.nih.gov/compound/56841945

• NCBI – Pralmorelin (GHRP-2)
  https://pubchem.ncbi.nlm.nih.gov/compound/Pralmorelin